Predictors of sleep disorders among patients with type 2 diabetes mellitus

Diabetes and Metabolic Syndrome: Clinical Research and Reviews

Volumn 10, Issue 4, 2016, Pages 213-220

  Gupta, Shaloo ^a   Wang, Zhixiao ^b  

^a KANTAR HEALTH   (United States)

^b EISAI INC   (United States)

Author keywords

Obesity; Sleep disorders; Sleep symptoms; Type 2 diabetes mellitus; Weight management

Indexed keywords

ADULT; ADULT DISEASE; ALCOHOL CONSUMPTION; ARTICLE; CIRCADIAN RHYTHM SLEEP DISORDER; COMORBIDITY; DAYTIME SOMNOLENCE; FEMALE; GROUPS BY AGE; HOT FLUSH; HOUSEHOLD INCOME; HUMAN; INCOME; INSOMNIA; LEG CRAMP; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NARCOLEPSY; NIGHT SWEAT; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PAIN; PARASOMNIA; PHYSICAL INACTIVITY; PREDICTOR VARIABLE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SELF REPORT; SEX DIFFERENCE; SLEEP DISORDER; SLEEP DISORDERED BREATHING; SLEEP QUALITY; SMOKING; UNEMPLOYMENT; COMPLICATION; FOLLOW UP; NEW JERSEY; PROGNOSIS;

ADULT; COMORBIDITY; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEW JERSEY; PREVALENCE; PROGNOSIS; RISK FACTORS; SLEEP WAKE DISORDERS;

EID: 84994894065     PISSN: 18714021     EISSN: 18780334     Source Type: Journal    
DOI: 10.1016/j.dsx.2016.06.009     Document Type: Article

References (31)

1. [1] Guariguata, L., Whiting, D.R., Hambleton, I., Beagley, J., Linnenkamp, U., Shaw, J.E., Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract 103 (2014), 137–149.
2. [2] Ng, M., Fleming, T., Robinson, M., Thomson, B., Graetz, N., Margono, C., et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 384 (2014), 766–781.
3. [3] McNeil, J., Doucet, E., Chaput, J.P., Inadequate sleep as a contributor to obesity and type 2 diabetes. Can J Diabetes 37 (2013), 103–108.
4. [4] Nedeltcheva, A.V., Scheer, F.A., Metabolic effects of sleep disruption, links to obesity and diabetes. Curr Opin Endocrinol Diabetes Obes 21 (2014), 293–298.
5. [5] Schmid, S.M., Hallschmid, M., Schultes, B., The metabolic burden of sleep loss. Lancet Diabetes Endocrinol 3 (2015), 52–62.
6. [6] Institute of Medicine Committee on Sleep M, Research. The National Academies Collection: Reports funded by National Institutes of Health. In: Colten HR, Altevogt BM, editors. Sleep Disorders and Sleep Deprivation: An Unmet Public Health Problem. Washington (DC): National Academies Press (US). National Academy of Sciences; 2006.
7. [7] Heffner, J.E., Rozenfeld, Y., Kai, M., Stephens, E.A., Brown, L.K., Prevalence of diagnosed sleep apnea among patients with type 2 diabetes in primary care. Chest 141 (2012), 1414–1421.
8. [8] West, S.D., Nicoll, D.J., Stradling, J.R., Prevalence of obstructive sleep apnoea in men with type 2 diabetes. Thorax 61 (2006), 945–950.
9. [9] Einhorn, D., Stewart, D.A., Erman, M.K., Gordon, N., Philis-Tsimikas, A., Casal, E., Prevalence of sleep apnea in a population of adults with type 2 diabetes mellitus. Endocr Pract 13 (2007), 355–362.
10. [10] Plantinga, L., Rao, M.N., Schillinger, D., Prevalence of self-reported sleep problems among people with diabetes in the United States, 2005–2008. Prev Chronic Dis, 9, 2012, E76.
11. [11] Shaw, J.E., Punjabi, N.M., Wilding, J.P., Alberti, K.G., Zimmet, P.Z., Sleep-disordered breathing and type 2 diabetes: a report from the International Diabetes Federation Taskforce on Epidemiology and Prevention. Diabetes Res Clin Pract 81 (2008), 2–12.
12. [12] Taub, L.F., Redeker, N.S., Sleep disorders, glucose regulation, and type 2 diabetes. Biol Res Nurs 9 (2008), 231–243.
13. [13] Tang, Y., Meng, L., Li, D., Yang, M., Zhu, Y., Li, C., et al. Interaction of sleep quality and sleep duration on glycemic control in patients with type 2 diabetes mellitus. Chin Med J (Engl) 127 (2014), 3543–3547.
14. [14] Meisinger, C., Heier, M., Loewel, H., Sleep disturbance as a predictor of type 2 diabetes mellitus in men and women from the general population. Diabetologia 48 (2005), 235–241.
15. [15] Chaput, J.P., Despres, J.P., Bouchard, C., Astrup, A., Tremblay, A., Sleep duration as a risk factor for the development of type 2 diabetes or impaired glucose tolerance: analyses of the Quebec Family Study. Sleep Med 10 (2009), 919–924.
16. [16] Yaggi, H.K., Araujo, A.B., McKinlay, J.B., Sleep duration as a risk factor for the development of type 2 diabetes. Diabetes Care 29 (2006), 657–661.
17. [17] Knutson, K.L., Ryden, A.M., Mander, B.A., Van Cauter, E., Role of sleep duration and quality in the risk and severity of type 2 diabetes mellitus. Arch Intern Med 166 (2006), 1768–1774.
18. [18] Martins, R.C., Andersen, M.L., Tufik, S., The reciprocal interaction between sleep and type 2 diabetes mellitus: facts and perspectives. Braz J Med Biol Res 41 (2008), 180–187.
19. [19] Bolge, S.C., Doan, J.F., Kannan, H., Baran, R.W., Association of insomnia with quality of life, work productivity, and activity impairment. Qual Life Res 18 (2009), 415–422.
20. [20] DiBonaventura, M.D., Wagner, J.S., Yuan, Y., L'Italien, G., Langley, P., Ray Kim, W., Humanistic and economic impacts of hepatitis C infection in the United States. J Med Econ 13 (2010), 709–718.
21. [21] Finkelstein, E.A., Allaire, B.T., DiBonaventura, M.D., Burgess, S.M., Direct and indirect costs and potential cost savings of laparoscopic adjustable gastric banding among obese patients with diabetes. J Occup Environ Med 53 (2011), 1025–1029.
22. [22] Charlson, M.E., Pompei, P., Ales, K.L., MacKenzie, C.R., A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chronic Dis 40 (1987), 373–383.
23. [23] World Health Organization, Global Health Risks: mortality and burden of disease attributable to selected major risks. 2009, World Health Organization.
24. [24] Akinnusi, M.E., Saliba, R., Porhomayon, J., El-Solh, A.A., Sleep disorders in morbid obesity. Eur J Intern Med 23 (2012), 219–226.
25. [25] Alkatib, S., Sankri-Tarbichi, A.G., Badr, M.S., The impact of obesity on cardiac dysfunction in patients with sleep-disordered breathing. Sleep Breath 18 (2014), 137–142.
26. [26] Slater, G., Pengo, M.F., Kosky, C., Steier, J., Obesity as an independent predictor of subjective excessive daytime sleepiness. Respir Med 107 (2013), 305–309.
27. [27] McNamara, J.P., Wang, J., Holiday, D.B., Warren, J.Y., Paradoa, M., Balkhi, A.M., et al. Sleep disturbances associated with cigarette smoking. Psychol Health Med 19 (2014), 410–419.
28. [28] Pan, A., Wang, Y., Talaei, M., Hu, F.B., Wu, T., Relation of active, passive, and quitting smoking with incident type 2 diabetes: a systematic review and meta-analysis. Lancet Diabetes Endocrinol 3 (2015), 958–967.
29. [29] Ohkuma, T., Iwase, M., Fujii, H., Kaizu, S., Ide, H., Jodai, T., et al. Dose- and time-dependent association of smoking and its cessation with glycemic control and insulin resistance in male patients with type 2 diabetes mellitus: the Fukuoka Diabetes Registry. PLoS One, 10, 2015, e0122023.
30. [30] Fujioka, K., Benefits of moderate weight loss in patients with type 2 diabetes. Diabetes Obes Metab 12 (2010), 186–194.
31. [31] Hauner, H., Managing type 2 diabetes mellitus in patients with obesity. Treat Endocrinol 3 (2004), 223–232.